Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB.p Marsh Regulatory News (BPM)

Share Price Information for B.p Marsh (BPM)

Share Price is delayed by 15 minutes
Get Live Data
701.00    11.00 (1.59%)
Bid:
692.00
Ask:
710.00
Spread: 18.00 (2.601%)
Market Cap: £247.03m
BPM Live PriceLast checked at - London Stock Exchange

Intraday B.p Marsh Share Chart

Interim Dividend Declaration

21 Jan 2026 07:00

RNS Number : 6817P
B.P. Marsh & Partners PLC
21 January 2026
 

21 January 2026

 

B.P. Marsh & Partners Plc

("B.P. Marsh", "the Company" or "the Group")

 

Interim Dividend Declaration

 

B.P. Marsh & Partners Plc (AIM: BPM), the specialist venture capital investor in early stage financial services businesses, is declaring an Interim Dividend of 6.98p per share (the "Interim Dividend").

 

The Company has previously announced its intention to distribute a £5.0m dividend for its 31 January 2027 financial year. The Board confirms that the dividend will be paid in two instalments: the Interim Dividend of 6.98p per share (£2.5m in aggregate) payable in February 2026, and the balance payable in July 2026 as a Final Dividend, subject to Shareholder Approval at the Company's Annual General Meeting ("the AGM"). The AGM is expected to be held in early July 2026.

 

The Interim Dividend of 6.98p per share will be payable on 27 February 2026 to all Shareholders on the Register on 30 January 2026. The associated ex-dividend date is 29 January 2026.

 

As announced on 15 December 2025, the Company will also pay a Special Dividend of 22.33p per share on 27 March 2026.

 

It remains the Company's intention to pay a dividend of at least £5.0m in the financial year ending 31 January 2028, subject always to the Board's right to recommend an increased or decreased Final Dividend, for example in the event of significant realisations or capital commitments.

 

The Board periodically reviews its allocation policy, including the frequency of dividend payments for subsequent years.

 

For further information on B.P. Marsh, its strategy and current portfolio, please visit www.bpmarsh.co.uk or contact:

 

B.P. Marsh & Partners Plc

Daniel Topping / Alice Foulk

 

Tel: +44 (0) 20 7233 3112

 

Nominated Adviser & Joint Corporate Broker:

 

Singer Capital Markets Advisory LLP

Tel: +44 (0) 20 7496 3000

Charles Leigh-Pemberton / Asha Chotai / James Todd

 

Joint Corporate Broker:

Investec Bank plc

Christopher Baird / David Anderson / Maria Gomez de Olea

 

Tel: +44 (0) 20 7597 5970

Financial PR & Investor Relations:

Tavistock

Simon Hudson / Katie Hopkins / Kuba Stawiski

 

Tel: +44 (0) 20 7920 3150

bpmarsh@tavistock.co.uk

 

-Ends-

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVPPUQUGUPQPPU
Date   Source Headline
24th Oct 20177:01 amRNSDirector/PDMR Shareholding
24th Oct 20177:00 amRNSDirector/PDMR Shareholding
19th Oct 20173:55 pmRNSDirector/PDMR Shareholding
17th Oct 20177:00 amRNSInterim Results
16th Oct 20177:00 amRNSInvestment in Mark Edward Partners LLC
7th Sep 20177:00 amRNSTrading Update
6th Sep 20177:00 amRNSDirectorate Change
31st Jul 20176:06 pmRNSDirector/PDMR Shareholding
31st Jul 20176:04 pmRNSDirector/PDMR Shareholding
27th Jul 20177:00 amRNSInvestee Company Update
24th Jul 20173:50 pmRNSShare Buy-Back Policy
19th Jul 20174:24 pmRNSResult of AGM
19th Jul 20179:16 amRNSInvestee Company Update
18th Jul 20172:07 pmRNSInvestee Company Update - Nexus Underwriting
13th Jul 20175:10 pmRNSInvestee Company Update
5th Jul 20173:25 pmRNSDirector/PDMR Shareholding
30th Jun 201710:36 amRNSInvestee Company Update - Nexus Underwriting
29th Jun 20173:26 pmRNSShare Incentive Plan
28th Jun 20173:07 pmRNSNotice of AGM
19th Jun 20173:20 pmRNSInvestment
14th Jun 20173:55 pmRNSDirector/PDMR Shareholding
14th Jun 20172:56 pmRNSDirector/PDMR Shareholding
13th Jun 20171:10 pmRNSInvestment in North America
12th Jun 20174:01 pmRNSDirector/PDMR Shareholding
12th Jun 20173:56 pmRNSDirector/PDMR Shareholding
9th Jun 20177:05 amRNSDirector/PDMR Shareholding
9th Jun 20177:00 amRNSDirector/PDMR Shareholding
6th Jun 20177:00 amRNSFinal Results
25th Apr 20171:17 pmRNSDirector/PDMR Shareholding
24th Apr 20174:40 pmRNSChange of Registered Office
19th Apr 20175:40 pmRNSResult of General Meeting
12th Apr 20174:07 pmRNSBesso Disposal Update
6th Apr 20175:36 pmRNSDirector/PDMR Shareholding
5th Apr 201712:28 pmRNSPDMR Share Sale Plan
3rd Apr 201712:43 pmRNSDisposal and Notice of General Meeting
16th Mar 20174:50 pmRNSTransaction in Own Shares
15th Mar 20175:04 pmRNSShare Buy-Back Policy Update
15th Mar 20175:02 pmRNSDirector/PDMR Shareholding
15th Mar 20172:47 pmRNSTransaction in Own Shares
14th Mar 20172:16 pmRNSTransaction in Own Shares
13th Mar 20173:56 pmRNSTransaction in Own Shares
10th Mar 20176:18 pmRNSTransaction in Own Shares
3rd Mar 20173:23 pmRNSTransaction in Own Shares
3rd Mar 20173:21 pmRNSDirector/PDMR Shareholding
3rd Mar 201711:12 amRNSShare Buy-Back Policy
28th Feb 20174:17 pmRNSDisposal
17th Feb 20174:36 pmRNSInvestment
7th Feb 20177:00 amRNSTrading Update
3rd Feb 201712:30 pmRNSDirector/PDMR Shareholding
30th Jan 20177:40 amRNSInvestment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.